RVFV N
Reactivity: Rift Valley Fever Virus (RVFV)
ELISA, LF
Host: Mouse
Monoclonal
unconjugated
Application Notes
RVF virus nucleocapsid antibody can detect 10 ng RVF virus nucleocapsid peptide in ELISA at 1 μ,g/mL.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Rift Valley Fever Virus Nucleocapsid Antibody is supplied in PBS containing 0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Rift Valley Fever Virus Nucleocapsid antibody can be stored at 4°C for three months and -20°C, stable for up to one year.
Target
RVFV N
(Rift Valley Fever Virus Nucleocapsid (RVFV N))
Alternative Name
Rift Valley Fever Virus Nucleocapsid
Target Type
Viral Protein
Background
Rift Valley Fever Virus Nucleocapsid Antibody: Rift Valley Fever (RFV) virus is an arthropod-borne virus endemic to Africa that infects humans and animals that is transmitted predominantly by mosquitoes (1). During human infections, symptoms can range from benign fever to severe encephalitis and fatal hepatitis with hemorrhagic fever. The Bunyaviridae family of viruses to which the RVF virus belongs are spherical enveloped viruses with a tripartite RNA genome of negative or ambisense polarity (2). The three segments are referred to as the L, M, and S segments. The L and M segments are negative polarity and code fore the L-dependent RNA polymerase and glycoprotein precursor respectively. The S segment is of ambisense polarity and encodes the nucleoprotein and non-structural proteins (3).